GBLB:EURONEXT BRUSSELSGroupe Bruxelles Lambert SA Analysis

The stock is trading at €9.31, just above the identified support level of €8.96 and marginally below the 20‑day SMA of €10.21, while the 50‑day SMA sits at €9.70, indicating a price that is testing short‑term moving averages. Technical momentum is positive with a bullish MACD histogram (+0.22) and a neutral RSI of 46, and the volume trend is increasing, suggesting renewed buying interest. However, the equity carries a high beta of 1.35 and a 30‑day volatility exceeding 200%, flagging significant price swings. On the valuation side, the price‑to‑book ratio is an ultra‑low 0.08 and the dividend yield stands at a robust 6.4%, yet earnings per share are negative (‑€0.32) and cash flow metrics are flat, raising questions about the sustainability of the payout. The balance sheet shows a debt‑to‑equity of 57.7 and total debt of €7.72 bn, outweighing the cash position of €4.13 bn, which amplifies financial risk.
Recent corporate actions provide mixed signals: the AGM on 7 May confirmed strategic decisions, the company executed a share‑repurchase program in late April, and it disclosed a €0.3 bn divestiture of its stake in Umicore, generating cash but also reducing exposure to a key holding. While the dividend remains attractive, the payout ratio of nearly 5 times earnings signals potential future cuts, and the lack of operating cash flow underscores ongoing profitability challenges.